These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28390428)

  • 1. Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report.
    Scarano M; Casale M; Mantini C; Imbalzano E; Consorti C; Clemente D; Dattilo G
    J Med Case Rep; 2017 Apr; 11(1):97. PubMed ID: 28390428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients.
    Ke HH; He Y; Lv XW; Zhang EH; Wei Z; Li JY
    J Thromb Thrombolysis; 2019 Aug; 48(2):270-276. PubMed ID: 31165950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
    Yang Y; Du X; Dong J; Ma C
    Am J Med Sci; 2019 Oct; 358(4):273-278. PubMed ID: 31543101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Li X; Ning M; Lyu J; Yang Y; Liu XH; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):606-610. PubMed ID: 30139010
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
    Szegedi N; Gellér L; Tahin T; Merkely B; Széplaki G
    Orv Hetil; 2016 Jan; 157(4):154-6. PubMed ID: 26772828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracardiac Thrombus Following Rivaroxaban Treatment in a Patient with Atrial Fibrillation Associated with Rheumatic Heart Disease.
    Ohara H; Yamamoto S; Nagano K; Hashikawa K
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104325. PubMed ID: 31427189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Rivaroxaban a Safe Choice for Apical Thrombus in Atrial Fibrillation Patients? A Case Report.
    Aydin F; Turgay Yildirim O; Huseyinoglu Aydin A; Dagtekin E; Aksit E
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e203-e205. PubMed ID: 29735275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
    Marsico F; Cecere M; Parente A; Paolillo S; de Martino F; Dellegrottaglie S; Trimarco B; Perrone Filardi P
    J Thromb Thrombolysis; 2017 Feb; 43(2):139-148. PubMed ID: 27614756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.
    Watanabe T; Shinoda Y; Ikeoka K; Minamisaka T; Fukuoka H; Inui H; Hoshida S
    Intern Med; 2017; 56(15):1977-1980. PubMed ID: 28768967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report.
    Schiavoni M; Coluccia A
    J Med Case Rep; 2016 Oct; 10(1):276. PubMed ID: 27716428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Closure Device Thrombosis Despite Therapeutic Anticoagulation with Rivaroxaban.
    Walkin S; Patel K; Moustafa A; Grande R
    Cardiovasc Revasc Med; 2023 Aug; 53():76-79. PubMed ID: 37127481
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to the Editor: Warfarin versus non-vitamin K oral anticoagulants for left atrial appendage thrombus: A meta-analysis.
    Murtaza G; Turagam MK; Garg J; Velagapudi P; Atti V; Lakkireddy D
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2263. PubMed ID: 32495476
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of Left Atrial Appendage Thrombus with Apixaban in a Patient with Heart Failure.
    Okada T; Takaekou Y; Idei N; Ohashi N; Kaseda S
    Intern Med; 2017 Nov; 56(21):2891-2894. PubMed ID: 28943564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; van Eickels M; Cohen A;
    Am Heart J; 2016 Aug; 178():126-34. PubMed ID: 27502860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
    Abraham NS; Singh S; Alexander GC; Heien H; Haas LR; Crown W; Shah ND
    BMJ; 2015 Apr; 350():h1857. PubMed ID: 25910928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of thrombus outside a ligated left atrial appendage despite prolonged oral anticoagulant therapy.
    Vizzardi ME; Bottio T; Faggiano P; Zanini G; Antonioli E; Fracassi F; Chiari E; Muneretto C; Dei Cas L
    Minerva Cardioangiol; 2008 Jun; 56(3):377-8. PubMed ID: 18509299
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY; Hammerstingl C; Marin F; Cappato R; Meng IL; Kirsch B; Morandi E; van Eickels M; Cohen A
    Am Heart J; 2015 Apr; 169(4):464-71.e2. PubMed ID: 25819852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.